OR WAIT null SECS
Nihal Tugcu is senior principal scientist at Bioprocess Development, Merck Sharp & Dohme Corp, Kenilworth, New Jersey, USA.
The authors discuss the evolution of the purification platform for manufacturing of mAb therapeutics.